News and Announcements
SUDA Files Patent Application For Novel Mucosal Penetration Technology
- Published November 03, 2016 5:08PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
2 November 2016, ASX Announcment
SUDA LTD (ASX: SUD), a leader in oro-mucosal drug delivery, today announced that it has filed a provisional patent application with IP Australia for a novel mucosal penetration drug delivery technology. The application was filed under the international Patent Cooperation Treaty (PCT), which enables SUDA to seek patent protection for its technology in more than 145 countries.
The technical field of the provisional patent application is entitled: ‘A method for modifying the penetration of active agents through mucosal membranes using hydrotopes.’
To view the full announcement, please click on the button below.